Vertical Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vertical Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12374
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vertical Pharmaceuticals LLC (Vertical Pharmaceuticals), a subsidiary of Osmotica Pharmaceutical Corp, is a medicines marketing company that supplies niche prescription medicines. The company offers product category includes women’s health and pain management. It provides products such as Corvite FE, Divigel, Provella, Lorzone, and ConZip. Vertical Pharmaceuticals women’s health products are used in the treatment of menopausal symptom relief and probiotics for digestive health and wellness benefits. The company’s pain management products are used in the treatment of chronic pain and pain associated with acute, musculoskeletal conditions. Vertical Pharmaceuticals is headquartered in Bridgewater, New Jersey, the US.

Vertical Pharmaceuticals LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 10
Partnerships 12
Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 12
Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 13
Vertical Pharmaceuticals LLC – Key Competitors 14
Vertical Pharmaceuticals LLC – Key Employees 15
Vertical Pharmaceuticals LLC – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 2
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vertical Pharmaceuticals LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 10
Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 12
Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 13
Vertical Pharmaceuticals LLC, Key Competitors 14
Vertical Pharmaceuticals LLC, Key Employees 15

List of Figures
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vertical Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Vertical Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caladrius Biosciences Inc (CLBS)-医療機器分野:企業M&A・提携分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc is a clinical stage development company that develops and manufactures cell therapy products. The company’s products are based on its proprietary technologies such as Dendritic Cell-Tumor Cell technology; CD34 technology; and T Regu …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Edwards Lifesciences Corporation (EW):企業の財務及び戦略的SWOT分析
    Edwards Lifesciences Corporation (EW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Primerica, Inc.:企業の戦略・SWOT・財務分析
    SummaryPrimerica, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Thrive Bioscience Inc:企業のM&A・提携動向(医療分野)
    Summary Thrive Bioscience Inc (Thrive Bioscience) is a development stage life science analytical and automation technology company. It focuses on the development of cell structure instruments based on the analytical and automation technology for life science companies. The company’s innovative syste …
  • IVF Hartmann Holding AG (VBSN):企業の財務及び戦略的SWOT分析
    Summary IVF Hartmann Holding AG (IVF Hartmann), a subsidiary of Paul Hartmann AG is a medical device company that offers patient care products and services. The company develops, produces, and markets medical, pharmaceutical and hygiene products to the healthcare market. Its product segments include …
  • Teradyne, Inc.:企業の戦略・SWOT・財務情報
    Teradyne, Inc. - Strategy, SWOT and Corporate Finance Report Summary Teradyne, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Acelon Chemicals & Fiber Corporation (1466):企業の財務及び戦略的SWOT分析
    Summary Acelon Chemicals & Fiber Corporation (Acelon Chemicals) is a chemical manufacturer that produces and sells various textile chemical filaments and yarns. The company’s products include nylon 6 yarn, nylon 66 yarn, polyester yarn, functional yarn, cool yarn, polyester antistatic yarn, acestati …
  • AxioMed Spine Corporation:(医療機器分野)企業M&A及び提携動向
    Summary AxioMed Spine Corporation (AxioMed) is a medical device company. The company develops spinal disc replacement products for patients with degenerative spine disease. It designs and develops products operated on spinal function for patients with degenerative spine diseases. AxioMed also develo …
  • Kendrion N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Kendrion N.V. Mergers and Acqui …
  • Berjaya Corporation Berhad:企業の戦略・SWOT・財務分析
    SummaryBerjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • MaxCyte, Inc.(製薬・医療分野):企業M&A動向
    Summary MaxCyte, Inc. (MaxCyte) is a biotherapeutics company. The company offers cell-based therapies for chronic and acute diseases. It offers products such as MaxCyte STX, MaxCyte VLX and MaxCyte GT. The company offers services such as transfection insourcing services, processing assemblies and qu …
  • Powerit Solutions, LLC:企業のM&A・提携動向(エネルギー分野)
    Summary Powerit Solutions, LLC (Powerit), a subsidiary of Powerit Holdings, Inc. is an energy management technology company that offers energy management systems. The company offers solutions such as spara demand control, spara demand response, spara dynamic pricing and spara microgrid control. Its …
  • Hebei Construction and Investment Group Co, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hebei Construction and Investme …
  • Siemens AG (SIE):企業の財務及び戦略的SWOT分析
    Siemens AG (SIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ply Gem Holdings, Inc.:企業の戦略・SWOT・財務分析
    SummaryPly Gem Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Los Angeles Department of Water and Power:企業のM&A・提携動向(エネルギー分野)
    Summary Los Angeles Department of Water and Power (LADWP) is a utility service provider that offers water and power, and related services. The utility provides services which include power and water supply, electric rates information, billing, water conservation, water resource planning, water quali …
  • RWE AG (RWE)-エネルギー分野:企業M&A・提携分析
    Summary RWE AG (RWE) is an energy company that generates, transmits and distributes electricity. The company generates electricity using various sources such as gas, hard coal, lignite, nuclear, hydro, biomass and renewables. It also produces oil, gas and lignite; and distributes and supplies gas. T …
  • AesRx, LLC.(製薬・医療分野):企業M&A動向
    Summary AesRx, LLC. (AesRx) is a biopharmaceutical company. The company develops and manufactures drugs for the treatment of sickle cell and other orphan disease. Its drug development programs include Aes-103 and Aes-210 products. AesRx’s Aes-103 is used in the treatment of sickle cell disease. The …
  • Phoenix Solar AG (PS4):企業の財務及び戦略的SWOT分析
    Phoenix Solar AG (PS4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆